<DOC>
	<DOC>NCT00739739</DOC>
	<brief_summary>The purpose of this study is to determine whether PD 0299685 is effective in the treatment of symptoms associated with interstitial cystitis/painful bladder syndrome, such as pain, urinary urgency and frequency. At the same time assess the drug's safety and tolerability.</brief_summary>
	<brief_title>An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis, Interstitial</mesh_term>
	<criteria>Men and women over 18 years of age with moderate to severe interstitial cystitis defined by pain score. Women must not be pregnant or lactating, They may be postmenopausal, surgically sterilized or using an appropriate method of contraception. History of interstitial cystitis less than 6 months History of current or recurrent urinary tract infections, or genitourinary cancer Any previous urinary diversion procedure with or without bladder removal, bladder augmentation Use of certain drugs given into the bladder up to 1 month prior to study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>